Evidence map›Paper›PMID 40722868›Full record

ArticleAntioxidants (Basel, Switzerland)2025

Morin Flavonoid Interaction with Albumin and Its Nanoparticle Conjugation: An Efficient Antioxidant Vehicle for Nutraceuticals.

Guillermo Montero, Víctor Guarnizo-Herrero, Catalina Sandoval-Altamirano, Germán Günther, Soledad Bollo, Francisco Arriagada, Javier Morales

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Guillermo MonteroFacultad de Ciencias, Universidad San Sebastián, Santiago 7510157, Chile.
Víctor Guarnizo-HerreroFacultad de Farmacia, Universidad de Alcalá, 28805 Alcalá de Henares, Spain.ORCID 0000-0001-9323-3388
Catalina Sandoval-AltamiranoFacultad de Química y Biología, Universidad de Santiago de Chile, Santiago 9170002, Chile.ORCID 0000-0002-8550-3218
Germán GüntherFacultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Santiago 8380492, Chile.ORCID 0000-0002-4733-8426
Soledad BolloFacultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Santiago 8380492, Chile.ORCID 0000-0003-0868-4294
Francisco ArriagadaFacultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Santiago 8380492, Chile.ORCID 0000-0001-8404-6492
Javier MoralesFacultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Santiago 8380492, Chile.ORCID 0000-0002-3190-2168

Funding

FONDECYT 1221145
6 · The paper itself

Abstract

Morin is a natural flavonoid with potent antioxidant activity, yet its clinical and nutraceutical applications remain limited due to poor aqueous solubility and low bioavailability. This study explores the interaction of morin with bovine serum albumin (BSA) and the development of BSA-based nanoparticles as a delivery platform. Fluorescence spectroscopy confirmed the formation of a stable 1:1 morin-BSA complex, governed by hydrophobic interactions, with a binding constant (Ka) of 1.87 × 10

Indexed as

albumin nanoparticlesencapsulationflavonoidfunctional foodmorinnutraceuticals

Identifiers

PMID40722868
PMCPMC12291850

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.